Blog
45 Articles
![Dr. Neeha Zaidi](https://letswinpc.org/wp-content/uploads/2022/10/Neeha-Zaidi.jpg)
New Immunotherapy Strategy Aimed at High-Risk Population
Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.
![Dr. Elizabeth Jaffee](https://letswinpc.org/wp-content/uploads/2022/10/Elizabeth-Jaffee.jpg)
New Clinical Accelerator Initiative Shortens Time from Bench to Clinic
Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.
![vaccine vial and syringe](https://letswinpc.org/wp-content/uploads/2022/09/ct2021oct27.jpg)
A Vaccine To Boost Immune Response to Pancreatic Cancer
Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.
![COVID-19 vaccine vial and syringe](https://letswinpc.org/wp-content/uploads/2021/03/COVID-19_Vaccine_vial_and_syringe.jpg)
Should Cancer Patients Get the COVID-19 Vaccine? Yes!
Should pancreatic cancer patients get the COVID-19 vaccine? According to the experts, yes, and as soon as they can.
![Dr. Beatriz Carreno](https://letswinpc.org/wp-content/uploads/2022/10/Beatriz-Carreno.jpg)
Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.
![Pancreatic Cancer Collective and Lustgarten logo and the Stand Up To Cancer logos](https://letswinpc.org/wp-content/uploads/2022/10/PCC-logo.gif)
Challenge Grant Recipients Moving Forward
The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.
![computer rendering of DNA in Brown and blue against a black background](https://letswinpc.org/wp-content/uploads/2022/09/ct2020mar2.jpg)
Testing the Safety of an Immunotherapy Combination After Surgery
A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.
![Dr. Vinod Balachandran](https://letswinpc.org/wp-content/uploads/2022/10/Balachandran.jpg)
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
![DNA helix made of multicolor dots on a bright blue background](https://letswinpc.org/wp-content/uploads/2022/09/ct2018sep21.jpg)
Personalized Immunotherapy Vaccine for Pancreatic Cancer
Researchers are creating a personalized vaccine to stimulate a pancreatic cancer patient’s immune system after surgery and chemotherapy.
![Dr. Vinod Balachandran](https://letswinpc.org/wp-content/uploads/2022/10/Balachandran.jpg)
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.